Medpace Holdings, Inc. (MEDP)
620.10
-0.66
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
620.10
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings EPS Diluted (Quarterly) : 4.250 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.250 |
| March 31, 2026 | 4.277 |
| December 31, 2025 | 4.666 |
| September 30, 2025 | 3.857 |
| June 30, 2025 | 3.097 |
| March 31, 2025 | 3.673 |
| December 31, 2024 | 3.671 |
| September 30, 2024 | 3.005 |
| June 30, 2024 | 2.754 |
| March 31, 2024 | 3.204 |
| December 31, 2023 | 2.459 |
| September 30, 2023 | 2.220 |
| June 30, 2023 | 1.933 |
| March 31, 2023 | 2.265 |
| December 31, 2022 | 2.117 |
| September 30, 2022 | 2.046 |
| June 30, 2022 | 1.464 |
| March 31, 2022 | 1.685 |
| December 31, 2021 | 1.325 |
| September 30, 2021 | 1.291 |
| June 30, 2021 | 1.056 |
| March 31, 2021 | 1.144 |
| December 31, 2020 | 1.346 |
| Date | Value |
|---|---|
| September 30, 2020 | 1.094 |
| June 30, 2020 | 0.644 |
| March 31, 2020 | 0.7594 |
| December 31, 2019 | 0.7839 |
| September 30, 2019 | 0.632 |
| June 30, 2019 | 0.7322 |
| March 31, 2019 | 0.5134 |
| December 31, 2018 | 0.6096 |
| September 30, 2018 | 0.52 |
| June 30, 2018 | 0.45 |
| March 31, 2018 | 0.40 |
| December 31, 2017 | 0.30 |
| September 30, 2017 | 0.25 |
| June 30, 2017 | 0.23 |
| March 31, 2017 | 0.20 |
| December 31, 2016 | -0.0005 |
| September 30, 2016 | 0.13 |
| June 30, 2016 | 0.1219 |
| March 31, 2016 | 0.0847 |
| December 31, 2015 | -0.2108 |
| September 30, 2015 | -0.0033 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 1.530 |
| Charles River Laboratories International, Inc. | -0.0309 |
| Avantor, Inc. | 0.0563 |
| Champions Oncology, Inc. | -0.048 |
| Personalis, Inc. | -0.3005 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 121.36M |
| Revenue (Quarterly) | 707.33M |
| Total Expenses (Quarterly) | 585.97M |
| Enterprise Value | 16.92B |
| Gross Profit Margin (Quarterly) | 27.56% |
| Profit Margin (Quarterly) | 17.16% |
| Earnings Yield | 2.75% |
| Operating Earnings Yield | 3.26% |
| Normalized Earnings Yield | 2.750 |